Question

Why are most pharmaceutical companies not interested in developing new antibiotics?

Why are most pharmaceutical companies not interested in developing new antibiotics?

Homework Answers

Answer #1
  • Antibiotics are medicines that help to cure infections or diseases caused by bacteria.
  • Nowadays developing new antibiotics is really challenging,time consuming ,expensive and also in certain cases they will not provide result because  the bacteria will acquire resistance against the antibiotics after a long term use.
  • Most of the pharmaceutical companies are not developing new antibiotics because they won't get a satisfying profit from the market the main reason is that people are aware of the fact that overuse of antibiotics will give resistance against the  particular antibiotics. Because of the ,low sales and low prices in the antibiotics marketing many pharmaceutical companies have started to pull out of the field of antibiotic research.
Know the answer?
Your Answer:

Post as a guest

Your Name:

What's your source?

Earn Coins

Coins can be redeemed for fabulous gifts.

Not the answer you're looking for?
Ask your own homework help question
Similar Questions
Explain why biotech companies are willing to sell their patents to big pharmaceutical companies and why...
Explain why biotech companies are willing to sell their patents to big pharmaceutical companies and why those big companies are willing to purchase the patents. Use a diagram to show the minimum and maximum price of the patent.
Pretend you are a researcher developing new antibiotics. You first need to choose a bacterial structure...
Pretend you are a researcher developing new antibiotics. You first need to choose a bacterial structure that would allow an antibiotic to target specific types of bacteria. In each case below, state one structure that would be an appropriate target for that group of bacteria. A. Gram Negative Bacteria B. Gram Positive Bacteria C. Acid Fast Bacteria D. All Bacteria
in developing the cash flows from operating activities most companies in the United States do what
in developing the cash flows from operating activities most companies in the United States do what
Which of the following is the most likely to happen when a pharmaceutical company obtains a...
Which of the following is the most likely to happen when a pharmaceutical company obtains a patent for a new vaccine? a. prices will be lower than without the patent. b. lower quantities of vaccines would be produced than without the patent. c. less incentives for pharmaceutical companies to invest in research and development. d. product will be priced higher than it would be without the exclusive rights.
why do penicillins and cephalosporins have a much higher therapeutic index than most other antibiotics?
why do penicillins and cephalosporins have a much higher therapeutic index than most other antibiotics?
A pharmaceutical company is interested in the development of a new analytical strategy for the analysis...
A pharmaceutical company is interested in the development of a new analytical strategy for the analysis of drug samples containing a wide range of hydrophobic and hydrophilic drug molecules. They either have boiling points of over 1100 oC and some decompose at temperatures slightly lower than this. Like many drugs, they fluoresce. a. What chromatographic technique would you use for this separation? b. What is the basis for separation in the technique you selected? c. Name and briefly discuss the...
Why are companies like Walmart and GAP developing their own supplier agreements? How does it differentiate...
Why are companies like Walmart and GAP developing their own supplier agreements? How does it differentiate them from other companies?
why it's important for Pharmaceutical companies invest at high scale in the development, trial, production, distribution...
why it's important for Pharmaceutical companies invest at high scale in the development, trial, production, distribution and marketing of innovative medications that are protected by a patent? give me some great examples on these factors make this particular drug very costly to patients and insurance companies; therefore, they have a high inelastic demand percentage.
3. Why do companies operating within the pharmaceutical and biotechnology industries typically sustain higher ROICs than...
3. Why do companies operating within the pharmaceutical and biotechnology industries typically sustain higher ROICs than firms in the technology, hardware, and equipment industries?
need quick answer You have recently graduated and are working for a new pharmaceutical company developing...
need quick answer You have recently graduated and are working for a new pharmaceutical company developing a drug to prolong the action of a neurotransmitter at a chemical synapse. Which of the following drugs should meet this goal? Group of answer choices A drug that is a blocker of the enzymatic degradation of the neurotransmitter in the synaptic cleft. A drug that is a postsynaptic receptor blocker. Two of these answers A drug is a blocker of the presynaptic synthesis...
ADVERTISEMENT
Need Online Homework Help?

Get Answers For Free
Most questions answered within 1 hours.

Ask a Question
ADVERTISEMENT